Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-24 @ 6:31 PM
NCT ID:
NCT05728957
Eligibility Criteria:
Inclusion Criteria:
* Participants diagnosed with a clinically localized (cT1) renal tumor ≤7cm in size with a solid component suspicious for malignancy based on cross-sectional imaging
* Pre-existing CT images of the mass with and without contrast or planned CT to ensure both with and without contrast images of the mass have been obtained within a 365-day window
* Participants must be greater than or equal to 18 years of age
* Eligible or planned to undergo partial or radical nephrectomy as determined by primary urologist
* Eligible or planned to receive renal mass biopsy as determined by primary urologist
* Estimated glomerular filtration rate of ≥30 ml/min/1.73 m2 as calculated by the CKD-EPI (Chronic Kidney Disease-Epidemiology Collaboration) Equation
Exclusion Criteria:
* Participants must not be pregnant (as determined by local policy by radiology / imaging center)
* Participants must not have evidence of clinical nodal or distant metastasis.
* Participants must not have had a history of other malignancy with concern for renal metastasis.
* Participants must not have any known allergy to technetium or sestamibi.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05728957
Study Brief:
Protocol Section:
NCT05728957